# Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults

> **NCT06869187** · PHASE2 · RECRUITING · sponsor: **Autobahn Therapeutics, Inc.** · enrollment: 35 (estimated)

## Conditions studied

- Bipolar Disorder Depression

## Interventions

- **DRUG:** ABX-002

## Key facts

- **NCT ID:** NCT06869187
- **Lead sponsor:** Autobahn Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-28
- **Primary completion:** 2026-02-27
- **Final completion:** 2026-03-13
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06869187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06869187, "Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06869187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*